MRUSPhase 2 Readout

Combination cohort clinical update

Merus | Petosemtamab | Head and neck cancer

Catalyst details

Clinical trial completion and company event watch item.

Phase

Phase 2

Expected date

2026-10-01

Expected period

Q4 2026

Source type

manual

quarterupcoming
Source URL

Notes

This record is structured for public-source tracking and manual analyst override. The database stores date confidence separately from exact dates so quarter, half-year, and estimated guidance can be handled without inventing precision.

Open company detail

History of changes

No sample changes for this catalyst.